21-hydroxylase deficiency differential diagnosis
|
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency Microchapters |
|
Differentiating Congenital adrenal hyperplasia due to 21-hydroxylase deficiency from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
21-hydroxylase deficiency differential diagnosis On the Web |
|
American Roentgen Ray Society Images of 21-hydroxylase deficiency differential diagnosis |
|
21-hydroxylase deficiency differential diagnosis in the news |
|
Directions to Hospitals Treating Congenital adrenal hyperplasia due to 21-hydroxylase deficiency |
|
Risk calculators and risk factors for 21-hydroxylase deficiency differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ahmad Al Maradni, M.D. [2]
Overview
congenital adrenal hyperplasia due to 21-hydroxylase deficiency from 11-β hydroxylase deficiency, 17-α hydroxylase deficiency, and adrenal tumor.
Differentiating congenital adrenal hyperplasia due to 21-hydroxylase deficiency from other diseases
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency from other diseases such as:
- Androgen insensitivity syndrome
- 11-β hydroxylase deficiency
- 17-α hydroxylase deficiency
- Polycystic Ovarian Syndrome
- Adrenal tumor